
By Elizabeth Cohen, Last December, when advisers to the US Food and Drug Administration met to consider whether the agency should authorize Pfizer’s Covid-19 vaccine, it was generally understood that the answer would be yes. Nine months later, those advisers are meeting to discuss booster shots, and the situation is very different. It won’t be
More